Literature DB >> 25384627

Photopic negative response in branch retinal vein occlusion with macular edema.

Hidetaka Noma1,2, Tatsuya Mimura3, Manami Kuse4,5, Kanako Yasuda6, Masahiko Shimura6.   

Abstract

In patients with branch retinal vein occlusion (BRVO) and macular edema, the relations among full-field electroretinogram (ffERG) parameters and parameters of retinal function or morphology remain uncertain. The objective of this study was to investigate the correlations between parameters of the ffERG, including the photopic negative response (PhNR), and retinal functional or morphological parameters in these patients. In 62 consecutive BRVO patients (mean age: 68.5 ± 10.6 years; 32 women and 30 men), the amplitude and implicit time of the a-wave cone, b-wave cone, 30 Hz flicker, and PhNR were calculated from the ffERG. Microperimetry was employed to measure the macular sensitivity within the central 4°, 10°, and 20° fields, while macular thickness and volume within these fields were measured by optical coherence tomography. Best-corrected visual acuity (BCVA) was determined on the logarithm of the minimum angle of resolution scale. The cone b-wave, 30 Hz flicker, and PhNR amplitudes showed a significant correlation with BCVA. In addition, the cone a-wave, cone b-wave, 30 Hz flicker, and PhNR amplitudes all showed a significant correlation with macular sensitivity within the central 4°, 10°, and 20° fields. Only the 30 Hz flicker amplitude showed a significant correlation with the macular thickness and volume within the 4°, 10°, and 20° fields, while the other ERG parameters did not. These findings suggest that PhNR may be a useful ERG parameter for evaluating inner retinal function in BRVO patients.

Entities:  

Keywords:  Branch retinal vein occlusion; Macular edema; Macular sensitivity; Macular thickness; Macular volume; Photopic negative response

Mesh:

Year:  2014        PMID: 25384627     DOI: 10.1007/s10792-014-0012-z

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  16 in total

1.  The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity.

Authors:  S Viswanathan; L J Frishman; J G Robson
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  The photopic negative response of the flash electroretinogram in retinal vein occlusion.

Authors:  Hongling Chen; Dezheng Wu; Shizhou Huang; Hong Yan
Journal:  Doc Ophthalmol       Date:  2006-08-30       Impact factor: 2.379

3.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

4.  Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Seiyo Harino; Takeshi Sugawara; Tatsuya Mimura; Katsunori Shimada
Journal:  Doc Ophthalmol       Date:  2011-07-30       Impact factor: 2.379

5.  The photopic negative response of the flash electroretinogram in primary open angle glaucoma.

Authors:  S Viswanathan; L J Frishman; J G Robson; J W Walters
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

6.  Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema.

Authors:  Hidetaka Noma; Hideharu Funatsu; Tatsuya Mimura; Seiyo Harino; Katsunori Shimada
Journal:  Retina       Date:  2011-11       Impact factor: 4.256

7.  Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.

Authors:  H Noma; H Funatsu; M Yamasaki; H Tsukamoto; T Mimura; T Sone; T Hirayama; H Tamura; H Yamashita; A Minamoto; H K Mishima
Journal:  Eye (Lond)       Date:  2006-07-07       Impact factor: 3.775

8.  The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma.

Authors:  S Viswanathan; L J Frishman; J G Robson; R S Harwerth; E L Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-05       Impact factor: 4.799

9.  Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; A Chang
Journal:  Arch Ophthalmol       Date:  1996-10

10.  Macular oedema and retinal branch vein occlusion.

Authors:  D V Greer; I J Constable; R L Cooper
Journal:  Aust J Ophthalmol       Date:  1980-08
View more
  5 in total

1.  Intensity response function of the photopic negative response (PhNR): effect of age and test-retest reliability.

Authors:  Nabin R Joshi; Emma Ly; Suresh Viswanathan
Journal:  Doc Ophthalmol       Date:  2017-05-15       Impact factor: 2.379

2.  Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab.

Authors:  Yoshihito Sakanishi; Ami Lee; Ayumi Usui-Ouchi; Rei Ito; Nobuyuki Ebihara
Journal:  Clin Ophthalmol       Date:  2016-06-21

Review 3.  New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion.

Authors:  Jia Li; Yannis M Paulus; Yuanlu Shuai; Wangyi Fang; Qinghuai Liu; Songtao Yuan
Journal:  J Ophthalmol       Date:  2017-03-12       Impact factor: 1.909

4.  Impaired Ganglion Cell Function Objectively Assessed by the Photopic Negative Response in Affected and Asymptomatic Members From Brazilian Families With Leber's Hereditary Optic Neuropathy.

Authors:  Gabriel Izan Santos Botelho; Solange Rios Salomão; Célia Harumi Tengan; Rustum Karanjia; Felipo Victor Moura; Daniel Martins Rocha; Paula Baptista Eliseo da Silva; Arthur Gustavo Fernandes; Sung Eun Song Watanabe; Paula Yuri Sacai; Rubens Belfort; Valerio Carelli; Alfredo Arrigo Sadun; Adriana Berezovsky
Journal:  Front Neurol       Date:  2021-01-18       Impact factor: 4.003

Review 5.  Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Authors:  Oliver R Marmoy; Suresh Viswanathan
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.